0
Skip to Content
PAREA
PAREA
Home
About
Members
Meet the Team
Why
FAQs
Meet the Board
Reports & Finances
Policies & Procedures
Strategy & Planning
About
Members
Events
News
Events
Videos
Guest Posts
Support Us
PAREA
PAREA
Home
About
Members
Meet the Team
Why
FAQs
Meet the Board
Reports & Finances
Policies & Procedures
Strategy & Planning
About
Members
Events
News
Events
Videos
Guest Posts
Support Us
Home
Folder: About
Back
About
Members
Meet the Team
Folder: Learn
Back
Why
FAQs
Folder: Governance
Back
Meet the Board
Reports & Finances
Policies & Procedures
Strategy & Planning
Folder: MEP Action Group
Back
About
Members
Events
Folder: Latest
Back
News
Events
Videos
Guest Posts
Support Us
16/06/2025

Presentation of the results of ketamine-assisted therapy program for treatment resistant depression

Previous

From Lagging to Leading: Mental Health Innovation "Made in Europe" | Norrsken House Brussels

Next

Testimonial of Andrea Siclari, cancer patient, delivered at the EU Parliament event on 06.02.2025

You Might Also Like

Related Embedded Video Item Thumbnail SA TAIP seminar | Tadeusz Hawrot - "Psychedelic advances in the EU"
Related Embedded Video Item Thumbnail Addressing psychological distress in palliative care; the EU funded PsyPal project on psychedelic therapy | EUHPP webinar
Related Embedded Video Item Thumbnail From Lagging to Leading: Mental Health Innovation "Made in Europe" | Norrsken House Brussels
Related Embedded Video Item Thumbnail PAREA: psychedelic-assisted therapies in Europe
Related Embedded Video Item Thumbnail PSYCH Symposium: The Future of Psychedelic Medicine in the EU

Our Work

About
Why

Contact

tadeusz@parea.eu

© Parea 2024 | Privacy Policy